PROTACs in cancer therapy: targeted degradation of GPX4, PARP and epigenetic regulators
Journal of Enzyme Inhibition and Medicinal Chemistry · 31.12.2026 · 41 (1)
DOI: 10.1080/14756366.2026.2636394 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Enzyme Inhibition and Medicinal Chemistry, online erschienen am 26.03.2026. Verfasst von Sunny Periyasamy und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Massachusetts, Amherst, MA, USA. Hauptthemen laut MEDLINE: Antineoplastic Agents, Epigenesis, Genetic, Neoplasms, Phospholipid Hydroperoxide Glutathione Peroxidase. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 397 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of Massachusetts, Amherst, MA, USA.
- Department of Biology, University of Massachusetts, Amherst, MA, USA.
Förderung
- NCI NIH HHS
Zitieren
APA
Periyasamy, S., Jarrett, T., Truong, J., & Skouta, R. (2026). PROTACs in cancer therapy: targeted degradation of GPX4, PARP and epigenetic regulators. Journal of Enzyme Inhibition and Medicinal Chemistry, 41(1). https://doi.org/10.1080/14756366.2026.2636394
Vancouver
Periyasamy S, Jarrett T, Truong J, Skouta R. PROTACs in cancer therapy: targeted degradation of GPX4, PARP and epigenetic regulators. Journal of Enzyme Inhibition and Medicinal Chemistry. 2026;41(1). doi:10.1080/14756366.2026.2636394
BibTeX
@article{Periyasamy2026,
author = {Periyasamy, Sunny and Jarrett, Thyla and Truong, Joe and Skouta, Rachid},
title = {PROTACs in cancer therapy: targeted degradation of GPX4, PARP and epigenetic regulators},
journal = {Journal of Enzyme Inhibition and Medicinal Chemistry},
year = {2026},
volume = {41},
number = {1},
doi = {10.1080/14756366.2026.2636394}
}
EUVIMED